THE DEFINITIVE GUIDE TO MODAFINIL NORGE

No specific dose adjustment advisable when tofacitinib coadministered with potent CYP2C19 inhibitors; minimize tofacitinib dose if coadministered with equally reasonable CYP3A4 and strong CYP2C19 inhibitors .Nevertheless, the waking mechanism of modafinil is still to be totally exposed. The latest scientific studies documented that modafinil might